News
-
-
-
-
PRESS RELEASE
Press Release: NEJM publishes ALTUVIIIO XTEND-Kids phase 3 data supporting its potential to transform the treatment landscape for children with severe hemophilia A
NEJM publishes ALTUVIIIO XTEND-Kids phase 3 data showing high-sustained factor levels with once-weekly dosing in children with severe hemophilia A, effective bleed protection, and no inhibitor development to factor VIII -
-
PRESS RELEASE
Press Release: Dupixent positive phase 3 data in children one to 11 years of age with eosinophilic esophagitis published in NEJM
Positive phase 3 data of Dupixent in children aged 1-11 with eosinophilic esophagitis published in NEJM highlights significant histologic remission achieved and sustained improvements, potentially changing standard of care -
-
-
-
PRESS RELEASE
Press Release: Audrey Duval Derveloy appointed Global Head of Corporate Affairs, member of Sanofi’s Executive Committee
Audrey Duval Derveloy appointed Global Head of Corporate Affairs at Sanofi, joining Executive Committee. Responsible for stakeholder engagement and CSR strategy globally
